Eigen

Bridging the gaps between Radiology, Urology & Oncology, Eigen improves healthcare and quality of life through innovative breakthroughs in image-guided disease diagnosis and treatment. Our ingenuity and foresight, coupled with our ongoing involvement with the scientific and medical communities, positions us at the vanguard of emerging technology used for detecting, localizing and managing prostate cancer. Eigen holds numerous patents in its growing intellectual property portfolio.

Eigen adheres to the highest standard in medical device regulatory compliance. We place great importance on effective risk management, as well as the best practices specific to safe medical device design, manufacture and installation. Demonstrating overall industry excellence, ISO 13485 certification aligns Eigen with international regulatory requirements and permits us to pursue sales and distribution in Canada, EU countries, other European countries, Latin America, Iran, Turkey, China, HK, Philippines, Korea, Turkey, India, Mexico in addition to our leading role throughout the USA.

Company’s Keywords:

medical imaging, urology, radiology, prostate, biopsy, multi modality image fusion, targeted biopsy, mrtrus image fusion, fusion, research, development, prostate cancer, oncology, focal therapy planning, focal therapy